GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNenoySUd1c3Zqb25oTllmdm9NcjhBSVpZWUM0UVJ2bW5fUUFwdzRwNVc4cy1nSC1CRldNNFRiVlc1SjdBYmYxSGpBcFB0ZUUyLUc2VjI0UUt4aE1PY3FJSm4zQll2OUxuck1aajVtand0UUtQQ3NaVEFHdG5Oa0Z1WVhyM3dlVGxLdkdsSzNhbDYtaXpOb24zWEJ4cHVrRFdCLVFoaEhHMDFiSGF3TWZQOFhBVG1aQTdMYlNxYjlBY09NZ2I4TmJHTUo3Zw?oc=5" target="_blank">GSK's Jemperli meets main goal in mid-stage rectal cancer trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMPepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters
October 7, 2026 at 11:36 AMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AM